-
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Thursday, September 22, 2022 - 4:50pm | 3722The below report was authored by Brad Sorensen, CFA, Zacks Small Cap Research. You can find the original report here. BioStem Technologies (OTCMKTS: BSEM) is changing the skin graft market by using the natural properties of perinatal tissue. Revenues are rising and...